“…In fact, several phytochemical and pharmacological studies (Aybar et al, 2001;Genta et al, 2010;Valentová et al, 2005) of yacon leaves have been conducted in the recent decades. Although there is sufficient evidence of their potential activity in the treatment of hyperglycaemia and its complications, there is still disagreement about their safe use and the appropriate therapeutic dose (de Oliveira et al, 2011;Fernandes et al, 2005;Genta et al, 2010;Siriwan et al, 2011). In the current study, we demonstrated that both a 10% decoction of yacon leaves and enhydrin have a safety margin in Wistar rats at doses in which was demonstrated hypoglycaemic effects.…”